HER2-positive Gastric or Gastroesophageal Junction Adenocarcinoma
1 clinical trials · Condition
◉ Watch HER2-positive Gastric or Gastroesophageal Junction Adenocarcinoma
| Record | Firm | Date |
|---|---|---|
| A Study of BL-M07D1 Combination Therapy in Patients With Unresectable Locally Advanced or Metastatic HER2-positive Gastric or Gastroesophageal Junction Adenocarcinoma (NCT06423885) | Sichuan Baili Pharmaceutical Co., Ltd. | 2024-12-24 |
Track HER2-positive Gastric or Gastroesophageal Junction Adenocarcinoma automatically
Every clearance here is in the API, with alerts when new ones post.